Stocksigma LogoStocksigma Logo

Caplin Point Reports Strong Q2 FY27 Consolidated Results with PAT Growth of 13.8% YoY

Caplin Point Laboratories reported consolidated revenue from operations of ₹629.84 Cr for Q2 FY27, up 17.9% YoY and 3.2% QoQ, with EBITDA rising 16.8% YoY

Caplin Point Reports Strong Q2 FY27 Consolidated Results with PAT Growth of 13.8% YoY

Caplin Point Laboratories Ltd · Financial Result · 12 Nov 2026, 6:45 pm

Caplin Point Reports Strong Q2 FY27 Consolidated Results with PAT Growth of 13.8% YoY Caplin Point Laboratories reported consolidated revenue from operations of ₹629.84 Cr for Q2 FY27, up 17.9% YoY and 3.2% QoQ, with EBITDA rising 16.8% YoY to ₹256.51 Cr (38.7% margin) and PAT growing 13.8% YoY to ₹182.35 Cr. For H1 FY27, revenue reached ₹1,240.20 Cr (+18.8% YoY) and PAT reached ₹361.42 Cr (+16.2% YoY). Free cash reserves stood at ₹1,534 Cr as of 30th Sep'26, fully funding its ongoing ₹1,000+ Cr capex plan via internal accruals.

Original exchange filing (PDF)

More announcements from Caplin Point Laboratories Ltd

All Caplin Point Laboratories Ltd announcements